Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Ossur Hf : Registration of capital reduction of 6,354,662 shares completed


Posted on: 27 Mar 18

Announcement no. 24/2018
Reykjavik, 27 March 2018 

Registration of capital reduction of 6,354,662 shares completed

Reference is made to the Company's announcement no. 17/2018 published on 8 March 2018.

The capital reduction of ISK 6,354,662 nominal value was registered with the Icelandic Register of Enterprises today. 6,354,662 own shares with a nominal value of ISK 1 each were cancelled.

The share capital of Össur is now ISK 430,808,063 nominal value divided into the same number of shares with a nominal value of ISK 1 each. The Company currently holds 4,892,189 own shares.

The shares cancelled are expected to be removed from trading on Nasdaq Copenhagen with effect from 4 April 2018.

Further information

David Hreidarsson
Investor Relations
dohreidarsson@ossur.com
+354 515 1380

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without limitations.  Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy.  A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, EMEA and APAC, with additional distributors worldwide. www.ossur.com.

GlobeNewswire
globenewswire.com

Last updated on: 28/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.